Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beckman Coulter

This article was originally published in The Gray Sheet

Executive Summary

Ongoing efforts by hospital networks to standardize lab equipment for improved ease of use and cost savings leads to a "record" increase in supply agreements with integrated health networks in 2001, the blood testing instrument maker says. IHN contracts signed in 2001 are expected to generate $196.5 mil. over the next five years, including deals worth $103.5 mil. signed in the fourth quarter alone, according to Beckman Coulter. Corporate sales advance 10.1% to $578.3 mil. in the fourth quarter, boosting earnings by 12.3% to $48.3 mil., the firm reports Jan. 28. Separately, the Fullerton, California company rolls out its CEQ 8000 automated, integrated genetic analysis system for high-speed DNA sequencing, heterozygote detection, confirmatory sequencing, mutation analysis, allele identification, SNP scoring, microsatellite instability and amplified fragment length polymorphism fingerprinting...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT016032

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel